1. Endogenous Control Genes in Prostate Cells: Evaluation of Gene Expression Using ‘Real-Time’ Quantitative Polymerase Chain Reaction
- Author
-
Emmanuel Nna, Tracey Bailey, Ibtisam E. Tothill, and Linmarie Ludeman
- Subjects
Adult ,Male ,PCA3 ,Prostatic Hyperplasia ,Glucosephosphate Dehydrogenase ,Biology ,Polymerase Chain Reaction ,Specimen Handling ,Prostate cancer ,Prostate ,Cell Line, Tumor ,Biopsy ,Gene expression ,Biomarkers, Tumor ,TaqMan ,medicine ,Humans ,Adaptor Proteins, Signal Transducing ,Aged ,Glucuronidase ,Aged, 80 and over ,medicine.diagnostic_test ,Gene Expression Profiling ,Prostatic Neoplasms ,General Medicine ,Middle Aged ,Prostate-Specific Antigen ,medicine.disease ,Molecular biology ,Gene expression profiling ,Adaptor Proteins, Vesicular Transport ,Real-time polymerase chain reaction ,medicine.anatomical_structure ,Pseudogenes - Abstract
Objective: Our aims were to measure the level of expression of Abelson (ABL1), β-glucuronidase (GUS) and glucose-6-phosphate dehydrogenase (G6PD) genes in exfoliated urine cells from healthy and transrectal ultrasound biopsy patients with elevated prostate-specific antigen levels and/or abnormal digital rectal examinations or urinary symptoms indicative of prostate problems, as well as in archived formalin-fixed paraffin-embedded prostate materials. Materialsand Methods: Real-time quantitative polymerase chain reaction (RQ-PCR) was used to evaluate the suitability of the 3 control genes, i.e. ABL1, GUS and G6PD, as control genes for prostate cancer cells. Exfoliated urine cells from 30 healthy males, 53 male patients, 138 cases of archived paraffin-embedded prostate tissues and 3 prostate cell lines were sampled. All cells were lysed in guanidine isothiocyanate buffer from which RNA was extracted and converted to cDNA by random hexamer priming. RQ-PCR was performed using TaqMan chemistries. Results: There was no significant difference in the level of expression for each of the 3 control genes in the cell lines. There was a significant difference in GUS transcript level between patients and healthy controls in both urine and prostate tissue sections (p < 0.05). G6PD transcript numbers also differed significantly from those of GUS in the prostate cell lines and tissue sections (p < 0.05). The transcript numbers of all the control genes were significantly reduced in aged samples (p < 0.001). Conclusion: The ABL1 gene was the most stable control gene in both clinical specimens and cell lines. Therefore, we recommend its use to enable standardization and interlaboratory comparisons for the RQ-PCR of prostatic tumour markers.
- Published
- 2010
- Full Text
- View/download PDF